Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Plan For Adopting International Software Guideline Draws Industry Concern

Executive Summary

The US agency was hoping to boost regulatory harmonization with the wholesale adoption of an international guideline on standalone medical device software, but medtech companies are worried that the guideline does not link up with US legislation and requirements.


Related Content

IMDRF Closing Two Working Groups, Says Jobs Are Done
Hiring Plans Are Central To US FDA's Digital Health Plan
Industry Praise US FDA Software Pilot Program
Software Fast Track? US FDA Asks Developers To Envision 'Precheck' Program
Next Step In Global Convergence: FDA Looks To Make IMDRF Software Guidance Its Own





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts